Recombinant immunotoxins development for HER2-based targeted cancer therapies

Understanding the molecular mechanisms of cancer biology introduces targeted therapy as a complementary method along with other conventional therapies. Recombinant immunotoxins are tumor specific antibodies that their recognizing fragment is utilized for delivering modified toxins into tumor cells....

Descripción completa

Detalles Bibliográficos
Autores principales: Mahmoudi, Reza, Dianat-Moghadam, Hassan, Poorebrahim, Mansour, Siapoush, Samaneh, Poortahmasebi, Vahdat, Salahlou, Reza, Rahmati, Mohammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8422749/
https://www.ncbi.nlm.nih.gov/pubmed/34488747
http://dx.doi.org/10.1186/s12935-021-02182-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8422749/
https://www.ncbi.nlm.nih.gov/pubmed/34488747
http://dx.doi.org/10.1186/s12935-021-02182-6

Ejemplares similares